Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Term Effects of Leptin Withdrawal or Initiation in Lipodystrophy Independent of Energy Intake
NCT01778556Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2013
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in lipodystrophy, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2013; status: completed.
02
Drugs
metreleptin
03
Conditions
lipodystrophy
Beyond the preview
Go deeper on NCT01778556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01778556.